13F Pro Quality Score

42.9/100

Rank #1,830 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

28.3/100

Profitability

28.4/100

Balance Sheet

37.2/100

Earnings Quality

1.0/100

Free Cash Flow

39.2/100

Institutional Flow

72.6/100

Revenue Scale

82.2/100

Dilution Risk

82.3/100

OLN Stock Analysis & AI Quality Score

AI stock analysis and institutional research for OLIN Corp (OLN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OLN at 42.9/100 on a 32-signal composite quality model, placing it at rank #1,830 of 2,879 stocks — the bottom half of the AI-ranked universe. OLN scores in the top quartile across revenue scale (82.2). Areas of concern include earnings quality (1.0) and revenue growth (28.3), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q4 2025), OLIN Corp reports quarterly revenue of $1.7B, net income of $-143.2M, free cash flow of $321.2M. Top institutional holders of OLN by reported 13-F value include HOTCHKIS & WILEY CAPITAL MANAGEMENT, BlackRock,, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. OLN trades on the NYSE exchange and files with the SEC under CIK 74303. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OLN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OLIN Corp directly from SEC EDGAR. OLIN Corp's 13F Pro composite quality score has ranged between 8 and 74 since 2021, currently 42.9 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Revenue

Q4 2025

$1.7B

Net Income

Q4 2025

$-143.2M

Free Cash Flow

Q4 2025

$321.2M

ROIC

Q4 2025

-3.3%

D/E Ratio

Q4 2025

1.54

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-30.2% YoY
$6.54BFY 2024
FY20 $5.76BFY21 $8.91BFY22 $9.38BFY24 $6.54B

Net Income

-92.1% YoY
$105.0MFY 2024
FY20 $-969.9MFY21 $1.30BFY22 $1.33BFY24 $105.0M

Operating Income

-83.3% YoY
$296.5MFY 2024
FY20 $-746.7MFY21 $1.85BFY22 $1.78BFY24 $296.5M

EPS (Diluted)

-89.8% YoY
$0.91FY 2024
FY20 $-6.14FY21 $7.96FY22 $8.94FY24 $0.91

Total Assets

-5.8% YoY
$7.58BFY 2024
FY20 $8.27BFY21 $8.52BFY22 $8.04BFY24 $7.58B

Total Debt

+10.1% YoY
$2.84BFY 2024
FY20 $3.86BFY21 $2.78BFY22 $2.58BFY24 $2.84B

Op. Cash Flow

-73.8% YoY
$503.2MFY 2024
FY20 $433.0MFY21 $1.74BFY22 $1.92BFY24 $503.2M

Get alerted when OLN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for OLIN Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of OLN

Put OLN on your watchlist

Track score changes the day OLIN Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is OLN a good stock to buy?

13F Pro's AI-powered analysis of OLIN Corp (OLN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OLN are available on the OLN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own OLN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OLN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of OLIN Corp's investment landscape.